Wang, XB., Sang, Y., Han, Q. et al. Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy., CJIM 3, 21 (1997). https://doi.org/10.1007/BF02935430
Wang Xian-Bo, Sang Yan, Han Qing, et al. Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy. [J]. Chinese Journal of Integrative Medicine 3(1):21-25(1997)
Wang, XB., Sang, Y., Han, Q. et al. Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy., CJIM 3, 21 (1997). https://doi.org/10.1007/BF02935430DOI:
Wang Xian-Bo, Sang Yan, Han Qing, et al. Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy. [J]. Chinese Journal of Integrative Medicine 3(1):21-25(1997) DOI: 10.1007/BF02935430.
Effects of Tangshenkang capsule on diabetic nephropathyon diabetic nephropathy
摘要
Objective: To study the effects of Chinese herbal medicine Tangshenkang (TSK) capsule on diabetic nephropathy (DN).Method: Fifty-seven patients with DN were randomly divided into two groups
the TSK-treated group and the control group-Results: Serious disorders of metabolism showed in DN patients
displayed high levels of thromboxane B2/6-keto-prostaglandin F1α(TXB2/6-keto-PGFlα) ratio and lipid peroxide (LPO) as compared with those of healthy persons. After 6 weeks treatment with TSK
the urinary albumin level reduced obviously (by 51%)
renal plasma flow (RPF) increased
glomerular filtration rate and LPO levels decreased. A positive correlation was observed between albuminuria level and TXB2/6-keto-PGFlα ratio. The clearance rate of creatinine didn’t improve significantly. In the control group
no significant difference in the above-mentioned parameters between pre-treatment and post-treatment was found.Conclusion: TSK capsule possessed a significant effect in improving urinary albumin and glomerular function. These effects might be due to the property of TSK in adjusting TXB2/6-keto-PGFlα ratio and its lipid-peroxidation in DN patients.
Abstract
Objective: To study the effects of Chinese herbal medicine Tangshenkang (TSK) capsule on diabetic nephropathy (DN).Method: Fifty-seven patients with DN were randomly divided into two groups
the TSK-treated group and the control group-Results: Serious disorders of metabolism showed in DN patients
displayed high levels of thromboxane B2/6-keto-prostaglandin F1α(TXB2/6-keto-PGFlα) ratio and lipid peroxide (LPO) as compared with those of healthy persons. After 6 weeks treatment with TSK
the urinary albumin level reduced obviously (by 51%)
renal plasma flow (RPF) increased
glomerular filtration rate and LPO levels decreased. A positive correlation was observed between albuminuria level and TXB2/6-keto-PGFlα ratio. The clearance rate of creatinine didn’t improve significantly. In the control group
no significant difference in the above-mentioned parameters between pre-treatment and post-treatment was found.Conclusion: TSK capsule possessed a significant effect in improving urinary albumin and glomerular function. These effects might be due to the property of TSK in adjusting TXB2/6-keto-PGFlα ratio and its lipid-peroxidation in DN patients.